Abstract:OBJECTIVE:To study the expression of Smads proteins involved in TGF-beta1 signal transduction during the process of liver fibrosis in BALB/c mice infected with Schistosoma japonicum. METHODS:Thirty-four BALB/c mice were each infected with (20 +/- 1) S. japonicum cercariae. The mice were sacrificed at 8, 12, 16 and 24 weeks postinfection. Ten healthy BALB/c mice served as normal control group. The liver tissues were fixed in 10% formaldehyde for histology and immunohistochemistry assay. The single-egg granuloma area was measured in hematoxylin-eosin stain section. The degree of liver fibrosis was determined by Sirius red staining. Immunohistochemistry was used to observe the expression of Smad protein. RESULTS:The area of single-egg granuloma peaked at 8th week post-infection [(533 +/- 1.03) mm2], and with time passing, the area diminished, and the area of granuloma reduced to (2.94 +/- 1.69) mm2 at 24 weeks post-infection. The difference was significant among the 4 periods after infection in single-egg granuloma area (P < 0.05). Collagen fibers appeared around granulomas at 8 weeks (2.03 +/- 0.52) and increased gradually. At 24 weeks post-infection, the degree of liver fibrosis reached a peak (6.90 +/- 1.57), and the liver fibrosis degree was significantly different among infection groups (P < 0.05). Immunohistochemistry showed low expression level of Smad2/3 and Smad7 and inconspicuous level of Smad4 in livers of the normal mice. The expression of Smad2/3 was found mostly in the cytoplasm and nucleus of cells around granulomas at 8th week post-infection, and the positive area of Smad2/3 was (7.24 +/- 1.64)% by semi-quantity. At 12 weeks post-infection, the Smad2/3 protein expression level around granulomas and liver sinus reached the peak [(10.01 +/- l.07)%], and there was significant difference between infection groups and the control [(2.13 +/- 0.32)%]. A significant difference in the Smad2/3 protein expression level was found between 12 weeks post-infection group and 8 weeks or 16 weeks post-infection groups. The expression level of Smad4 was (8.81 +/- 1.13)% at 8th week post-infection, higher than that in the control [(4.83 +/- 1.15)%] (P < 0.05). There was no difference among the infected mice at different periods in the level of Smad4 (P > 0.05). After 8 weeks post infection, Smad7 protein sparsely appeared around the granuloma [(4.15 +/- 1.26)%] while it disappeared around liver sinus. At 12 weeks post-infection, the level of Smad7 protein was higher [(6.34 +/- 1.5)%], but with prolonged infection time, no significant difference was revealed (P > 0.05). The level of Smad7 in infected mice was higher than that in the control (P < 0.05). CONCLUSION:Resylts show high expression for Smad2/3 and Smad7 and low expression level of Smad4 during the process of liver fibrosis in BALB/c mice infected with Schistosoma japonicum.

Influence of Interferon-Γ Treatment on Smads Expression in Liver Fibrosis of Mice Induced by Schistosoma Japonica

[Expression of Smad Proteins in the Process of Liver Fibrosis in Mice Infected with Schistosoma Japonicum].

[Studies on Smads at Transcription Level in Liver Fibrosis of Mice with Schistosomiasis Japonica].

Study on the efficacy of IFN-γ gene-modified murine hepatocytes against hepatic fibrosis in Schistosomiasis japonica

IFN‐γ Gene Therapy by Intrasplenic Hepatocyte Transplantation: a Novel Strategy for Reversing Hepatic Fibrosis in Schistosoma Japonicum‐infected Mice

Effects of IL-18 on immunoregulation in mice infected with Schistosoma japonica following praziquantel treatment

Effect of Recombinant Interferon-γ Combined with Anluohuaxianwan on Expression of TIMP-1 and TGF-β1,mRNA in Hepatic Fibrosis of Mice Infected with Schistosoma Japonica

Effect of Acarbose on the 24-Hour Blood Glucose Profile and Pattern of Carbohydrate Absorption

Effect of Anluohuaxian Tablet Combined with Γ-Ifn on Schistosomal Liver Fibrosis

NLRP3 inflammasome inhibition decreases Schistosomiasis japonica-induced granulomatous inflammation and fibrosis in BALB/c mice

In vivo Therapeutic Effects and Mechanisms of Hydroxyasiaticoside Combined With Praziquantel in the Treatment of Schistosomiasis Induced Hepatic Fibrosis

Involvement of SIRT1 in amelioration of schistosomiasis-induced hepatic fibrosis by genistein

Intrasplenic Transplantation of IL-18 Gene-Modified Hepatocytes: an Effective Approach to Reverse Hepatic Fibrosis in Schistosomiasis Through Induction of Dominant Th1 Response

The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice

Dynamic changes of liver sinusoid in BALB/c mice infected with Schistosoma japonicum

Single-cell RNA sequencing to dissect the immunological network of liver fibrosis in Schistosoma japonicum-infected mice

Wertigkeit der MR-Angiographie bei der Darstellung intrakranieller Aneurysmen

Study on the Expression of Hepatic Procollagen Mrna in Schistosomiasis with Liver Fibrosis

Dysregulated Glucuronidation of Bilirubin Exacerbates Liver Inflammation and Fibrosis in Schistosomiasis Japonica through the NF-κB Signaling Pathway

The change of the hepatic fibrosis and pigment deposition in mice schistosomal liver fibrosis treated with combination of Anluohuaxian pilule and interferon-γ

A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III